Physician profile
Robert M Ore
NPI 1326213794
$5,338.24
in general payments reported to CMS, 2019-2025
8 companies · $2,737 in 2025
The $2,737 reported for 2025 was more than what 82% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.13 · 2022: $856 · 2023: $296 · 2024: $1,439 · 2025: $2,737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,000 · Food and Beverage: $1,509 · Travel and Lodging: $947 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,000.00 |
| Food and Beverage | $1,509.33 |
| Travel and Lodging | $946.93 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,478.12 | 2022-2025 | |
| Eisai INC. | $278.97 | 2023-2025 | |
| Pfizer INC. | $261.09 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $125.97 | 2023-2025 | Lynparza |
| Glaxosmithkline, LLC. | $101.87 | 2023 | Jemperli |
| Myriad Genetic Laboratories, INC. | $45.06 | 2023 | Precisetumor |
| Immunogen, INC. | $36.03 | 2023 | Elahere |
| Avanos Medical | $11.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.